SCO-267
CAS: 1656261-09-4
Ref. 3D-BS179509
| 1mg | 225.00 € | ||
| 2mg | 352.00 € | ||
| 5mg | 587.00 € | ||
| 10mg | 969.00 € | ||
| 25mg | 1,824.00 € |
Product Information
SCO-267 is a novel small molecule that has been shown to increase insulin sensitivity in mice by activating the protein kinase Akt3. SCO-267 is orally active and penetrates the blood brain barrier to exert its effects. It has been shown to improve glucose tolerance and insulin sensitivity in wild-type mice, as well as reduce plasma ALT levels in neonatal mice. SCO-267 also activates Akt3 in min6 cells, which are a pancreatic beta cell line. This activation leads to increased fatty acid oxidation and reduced triglyceride accumulation. In knockout mice, SCO-267 was shown to protect against fatty liver disease induced by chronic exposure to ethanol or high fat diet.
Chemical properties
Technical inquiry about: 3D-BS179509 SCO-267
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
